 |
The Centre for Cellular and Molecular Platforms (C-CAMP), a Dept. of Biotechnology, Govt. of India initiative, considered one of the most exciting centres for technology-based innovation in India in the field of life sciences. C-CAMP was established with the aim of enabling cutting-edge bio-science research & entrepreneurship. It has created and fostered an entrepreneur-friendly culture in & around nurturing academic environment through its various activities supporting early stage ideas to proof-of concept stage and validation studies for commercialization. Dr. Taslimarif Saiyed is the CEO of C-CAMP. Dr. Saiyed has a PhD in Neuroscience from Max Planck Institutes, Germany. At C-CAMP, he manages C-CAMP's technology platforms, growth strategies, strategic collaborations for new technology creation, training programmes, entrepreneurship and innovation accelerator unit. |
 |
The University of Edinburgh is one of the largest and most successful universities in the UK with an international reputation as a centre of academic excellence. The University is the leading research university in Scotland and is amongst the top ten in the United Kingdom. It is the University's stated aim that it wishes as far as possible to conduct its research and development activities on a trans-national basis. The pooling of research expertise, equipment and database resources contributes to major advances in science, technology and medicine worldwide. The Division of Pathway Medicine is a research centre in the College of Medicine and Veterinary Medicine at the University of Edinburgh. The Division is conducting pioneering research programmes in Infection Medicine, in vitro diagnostics and antimicrobial resistance. Dr Till Bachmann is a Reader in Personalised Medicine in Infectious Diseases and Deputy Head of the Division of Infection and Pathway Medicine at The University of Edinburgh. He is an expert in point of care detection of infectious diseases and antimicrobial resistance, conducting research at the interface of biomarkers and novel detection modalities. Till fulfils a variety of industrial and institutional advisory roles worldwide, such as being advisor for the Longitude Prize on Antibiotics, judge for the Discovery Award and EU Horizon Prize on Better Use of Antibiotics. He is coordinator of the JPIAMR Working Group on Rapid Diagnostic Tests and founder of AMR DxC, the international Antimicrobial Resistance Diagnostics Challenge competition. |
 |
Longitude Prize, a challenge with a prize fund of £10 million, has been launched to help solve one the greatest issues of our time. The prize has been developed and is being run by Nesta, the UK’s innovation foundation. It was launched by the Prime Minister at G8 2014, and is being supported by Innovate UK as funding partner. 300 years on from the original longitude prize, a new prize for a new century has been launched and the winning challenge, as voted by the public, was antibiotics. The antibiotics challenge will be open to anyone to solve with the objective to conserve antibiotics for future generations and revolutionise the delivery of global healthcare. To win the Prize teams need to develop a transformative point of care test that will help identify when antibiotics are needed and, if they are, which ones to use. The test must be accurate, affordable, rapid and easy to use in any location, anywhere in the world. Find out more at www.longitudeprize.org/enter. Follow on twitter @longitude_prize |